Exagen inc. to participate in 2021 icr conference

San diego, jan. 05, 2021 (globe newswire) -- exagen inc. (nasdaq: xgn), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, announced today that company management will participate in the 2021 icr conference, which takes place january 11-14, 2021. ron rocca, exagen's president and chief executive officer, and kamal adawi, exagen's chief financial officer, will participate in a virtual fireside chat on thursday, january 14 at 11:30 am et, which is accessible to conference attendees. management will also be participating in one-on-one meetings with investors during the event; meetings can be requested through the icr conference site.
XGN Ratings Summary
XGN Quant Ranking